Laboratorios Farmacéuticos Rovi is a Spanish specialty pharmaceutical company focused on low-molecular-weight heparins, other hospital and specialty medicines, and contract manufacturing of injectables. It is known for bemiparin and for producing enoxaparin biosimilars, serving hospitals and healthcare systems in Europe and beyond. A substantial part of its model is also CDMO manufacturing capacity for third-party injectable and specialty products.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 159.7 | — | 21.6 | — |
| Q3 2025 | 210.5 | — | 58 | — |
| Q4 2025 | 218.4 | — | 42.7 | — |
| Q1 2026 | 152.5 | — | 9.5 | — |
| Q2 2026 | 191.7 | 20% | 75 | 246.7% |
All markets — KeepWinning global stock screener
Other companies on Bolsa de Madrid: Vidrala, S.A. (VID), CIE Automotive, S.A. (CIE), Ebro Foods, S.A. (EBRO), Elecnor, S.A. (ENO), Viscofan, S.A. (VIS), Cementos Molins, S.A. (CMO)